Blog

In the Multiple Sclerosis Special Fall 2020 issue of Brain & Life, guest editor, Barbara Giesser, MD, FAAN, FANA, writes, “Living with multiple sclerosis requires patience and diligence, but the prognosis for leading a full life is better than ever.”

Congratulations to Tiffany Juarez, PhD, for receiving the Saint John’s Cancer Institute Q3 2020 Mission Spirit Award! Tiffany is an incredible Program Manager in the Department of Translational Neurosciences. She is an outstanding and dedicated caregiver who truly lives the spirit of our Mission and...

The Pacific Movement Disorders Center kicked off its new monthly Let's Talk Parkinson's webinar series featuring its specialists and care team providers on various topics in Parkinson's disease.

New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A...

There’s a perception that because there isn’t a cure for PD, that means there’s no treatment, no way to improve symptoms, no way to improve quality of life. This is absolutely WRONG – there’s always more we can do!

Howard R. Krauss, MD, has been elected Vice President of the Medical Board of California, reported in an official state announcement released November 13, 2020. In his role, he will, in collaboration with the President, and as a member of the Executive Committee, oversee various...

Addiction and depression are two of the most widespread conditions in all of medicine. After decades of research, doctors are still looking for alternatives for when medication and cognitive training don’t work, which is all too often.

A new self-administered drug for the treatment of Multiple Sclerosis has been approved by the US Food and Drug Administration (FDA). In a clinical trial, it outperformed an existing oral drug, with respect to decreasing relapses and new areas of nerve damage seen on MRI....

As physicians, we understand the tremendous value of cognitive, physical, and social activity in optimizing and preserving our abilities as we age. At first glance, it is easy to see COVID as an obstacle. However, there are many ways we can emerge from this period sharper, stronger and more resilient.

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...